MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Hospital Care Learning Collaborative: Sharing strategies to address the Parkinson’s Foundation Inpatient Clinical Care Standards

    A. Brooks, E. Buetow, H. Azmi, B. Walter, K. Amodeo, P. Pronovost (Miami, USA)

    Objective: The Parkinson’s Foundation made another significant step toward its vision to eliminate preventable harm and promote higher reliability in care with the launch of…
  • 2024 International Congress

    Evaluating Cognitive Status in Parkinson’s Disease Using a Software-based Eye-Tracking Platform: Preliminary Results of the PALOMA Clinical Trial

    M. Tosin, C. Goetz, R. Armstrong, C. Januario, B. Balint, P. Mir (Chicago, USA)

    Objective: To investigate the correlation between the cognitive status of Parkinson's disease (PD) patients and oculomotor parameters captured by a software-based eye-tracking platform using artificial…
  • 2024 International Congress

    Cognitive, Non-Motor, and Quality of Life Outcomes After STN or GPi DBS for Parkinson’s Disease: An Interim Report from the ADROIT NAPA Sub-Study

    M. Potter-Nerger, A. Gharabaghi, C. Torres Diaz, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Hamburg, Germany)

    Objective: To summarize the effect of subthalamic nucleus (STN) or globus pallidus internus (GPi) DBS on cognition, quality of life, and non-motor symptoms in patients…
  • 2024 International Congress

    Two parallel nigrostriatal subcircuits mediate the arousal effect of dopaminergic neurons in substantia nigra pars compacta

    HS. Liu, JW. Li, ZA. Hu, RC. Ren, XN. Xiong (Wuhan, China)

    Objective: This study systematically investigates the involvement of dopaminergic (DA) neurons in substantia nigra pars compacta (SNc) in wakefulness-sleep regulation and explores the underlying circuit…
  • 2024 International Congress

    Gender-Based Differences in Sleep Quality Among Hispanic Parkinson’s Disease Patients

    D. Piana-Castillo, C. Rodriguez-Alarcon, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: The study aims to evaluate sleep quality among male and female Hispanic PD patients using the Parkinson's Disease Sleep Scale (PDSS) Background: Parkinson's disease (PD) is acknowledged for its multifaceted…
  • 2024 International Congress

    Validation of the International Parkinson and Movement Disorder Society – Non-Motor Symptoms – Questionnaire (MDS-NMS-Q)

    D. Weintraub, KR. Chaudhuri, A. Schrag, P. Martinez-Martin, A. Rizos, E. Mamikonyan, J. Gallagher, J. Staunton, M. Pereira Fernandes, C. Rodriguez Blazquez (Philadelphia, USA)

    Objective: To validate the self-completed version of the International Movement Disorder Society – Non-Motor Rating Scale (MDS-NMS)1, named the MDS-NMS – Questionnaire (MDS-NMS-Q). Background: The…
  • 2024 International Congress

    Clinical correlates of apathy in Parkinson´s disease

    J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)

    Objective: To investigate the demographic and clinical correlates of apathy in a group of patients from a Movement Disorders clinic in Latin America. Background: Apathy…
  • 2024 International Congress

    The effect of comorbid chronic post-traumatic stress disorder in dream enactment behavior among veterans with Parkinson’s disease and REM sleep behavior disorder

    E. Sandoval, C. Josephs, T. Lin (Tucson, USA)

    Objective: 1. To determine the co-occurrence rate of PTSD in veterans with PD and RBD.2. To evaluate severity of dream enactment behavior (DEB) and rate…
  • 2024 International Congress

    Pharmacokinetic Intersections in Geriatric Neuropharmacology: A Parkinson’s Disease Case Study with Concomitant Refractory Major Depressive Disorder

    D. Nolasco, L. Schmidt, B. Carr (Gainesville, USA)

    Objective: This investigation delineates the pharmacokinetic intricacies encountered in the therapeutic management of a geriatric patient with Parkinson’s Disease (PD) concomitantly suffering from refractory Major…
  • 2024 International Congress

    Validation of PD Ascertainment in the VA Electronic Medical Record (EMR)

    S. Goldman, F. Weaver, L. Cao, S. Jugnundan, B. Gonzalez, K. Stroupe, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)

    Objective: To determine the validity of PD diagnostic codes in a large national electronic medical database and develop recommendations for maximizing ascertainment accuracy. Background: EMR-based…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley